Repairing long-term nerve-connection damage after moderate brain injury with MitoQ

Persistent Pre- and Post-Synaptic Changes After Moderate Traumatic Brain Injury and Mitigation with MitoQ

NIH-funded research Veterans Health Administration · NIH-11176707

This project sees if the antioxidant MitoQ can protect and restore the nerve connections damaged by moderate traumatic brain injury.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Decatur, UNITED STATES)
Project IDNIH-11176707 on NIH RePORTER

What this research studies

This work uses a mouse model of moderate traumatic brain injury to study long-lasting damage to nerve connections (synapses) and whether MitoQ, a mitochondria-targeted antioxidant, can prevent or repair that damage. The team will examine both presynaptic and postsynaptic structures and measure molecular signs of oxidative and proteolytic damage. Functional tests will look at neurotransmitter release and synaptic performance during subacute and chronic phases after injury. If MitoQ preserves synaptic proteins and lipids in these experiments, it could point toward treatments to help people recover brain function after moderate TBI.

Who could benefit from this research

Good fit: Ideal candidates for any future human studies would be people—often veterans—with a history of moderate TBI and ongoing cognitive, emotional, or daily-life difficulties.

Not a fit: People with only very mild, single concussions or those with very long-standing, severe brain damage may be less likely to benefit from synapse-targeted therapies.

Why it matters

Potential benefit: If successful, this work could lead to therapies that protect synapses after moderate TBI and improve recovery of thinking, mood, and everyday functioning.

How similar studies have performed: Other antioxidant strategies have shown promise in laboratory models, but long-term protection of synapses after moderate TBI is a relatively new area and not yet proven in humans.

Where this research is happening

Decatur, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.